TABLE 4.

Bleeding adverse events

Grade	Cohort A Treatment‐naïve (N = 18)			Cohort B Relapsed/refractory (N = 9)			All (N = 27)
	1	2	3–5	1	2	3–5	1	2	3–5
Any	5 (28)	0	0	3 (33)	1 (11)	0	8 (30)	1 (4)	0
Purpura	1 (6)	0	0	2 (22)	0	0	3 (11)	0	0
Epistaxis	1 (6)	0	0	1 (11)	0	0	2 (7)	0	0
Contusion	0	0	0	2 (22)	0	0	2 (7)	0	0
Traumatic hematoma	0	0	0	0	1 (11)	0	0	1 (4)	0
Anal hemorrhage	1 (6)	0	0	0	0	0	1 (4)	0	0
Hematoma	1 (6)	0	0	0	0	0	1 (4)	0	0
Mouth hemorrhage	1 (6)	0	0	0	0	0	1 (4)	0	0
Petechiae	1 (6)	0	0	0	0	0	1 (4)	0	0
Conjunctival hemorrhage	0	0	0	1 (11)	0	0	1 (4)	0	0
Hemorrhage subcutaneous	0	0	0	1 (11)	0	0	1 (4)	0	0

Number (%) of patients is shown.